STEM CELL BILL PASSES THIRTY-SEVEN VOTES SHORT OF VETO OVERRIDE: Dems Likely to Stretch Out Debate, Make It as Politically Painful as Possible for Bush and Opponents

i-f7cb4757359d17eb4e1bd57f9d2fce21-BushwEmbryoBaby.jpg

This afternoon, as expected, the House passed the stem cell funding bill, 253 to 174, falling well short of the 290 votes needed to overturn a Bush veto. Debate now moves to the Senate, where news reports peg support teetering right at the 2/3 majority needed in the chamber to override the anticipated presidential veto.

So what are the options and where are things headed? A range of possibilities exist, with many floated this week in press reports:

a) Supporters keep passing versions of the bill, and Bush keeps vetoing, until public pressure builds, and either House members shift their votes or Bush caves in. Back in the summer, when Bush used the first veto of his presidency to reject a similar stem cell bill, polls indicated that roughly 60% of the public disagreed with his decision. If supporters of the 2007 bill can move these opinion numbers up closer to 70-75%, then pressure will really start to mount on House members.

b) Advocates sweeten the pot for compromise by adding provisions to the bill that include funding for programs that donate unwanted frozen embryos to infertile women, a program favored by Bush; require extra ethical oversight for stem cell research; or increase funding for studies of non-embryonic cells.

c) In Senate debate, the bill is modified, meaning that upon Senate passage, the bill would go to conference. With this event, following a Bush veto, an override would be debated first in the Senate, where a 2/3 majority is likely to vote to overturn Bush's decision, thereby exerting pressure on the House to do the same. In combination with compromise provisions in the bill, this added pressure might be enough for some House members to switch their votes, reaching the needed 290 votes in the chamber.

As all of this plays out, expect a familiar strategic communication strategy from both sides, as I detailed earlier this week over at my Skeptical Inquirer Online column.

More like this

In the Senate, stem cell proponents figure that they have 66 to 67 votes lined up in support of the funding bill passed today in the House. As I previously noted, a number of options are on the table to overcome an anticipated Bush veto of the bill, but where does public opinion stand on the…
One of the primary goals of Congress since the Democrats' stunning November 2006 election victory has been restoring federal funding for embryonic stem cell research. President Bush first imposed the restrictions on embryonic stem cell research in August 2001. After the House voted in May 2005 to…
This week all eyes will be on Capitol Hill as Nancy Pelosi and the newly elected House majority push for stem cell legislation that would override President George W. Bush's tight limits on research funding. Supporters will need to achieve a super majority in both houses in order to stave off a…
Below I provide an overview of the Editorials printed at the national and major regional newspapers. Without exception, the newspapers denounce Bush's decision. Most go with the "moral inconsistency" angle: why prevent research that could save lives when the left over embryos at IVF clinics…

A Republican friend of mine (scientist at JPL) commented that Bush has this science policy, whether right or wrong, that was based on moral principles, and that Democrats were not prepared to respond at the time.

Okay, the other shoe has been dropped, now.

I'd advise avoidance of "Faith-based debate."

I also think about the way that Woody Allen handled cloning in "Sleeper." Which in turn leads to this breaking news:

Dante gets posthumous nose job - 700 years on

By Philip PullellaThu Jan 11, 1:18 PM ET

"Italian scientists have made a reconstruction of the face of the poet Dante some 700 years after he died and have found some surprises, particularly about the supposed shape of his famous aquiline nose..."